T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,230.00
-250.00 (-7.18%)
Jan 30, 2026, 3:30 PM KST
-5.92%
Market Cap153.65B
Revenue (ttm)20.67B +297.7%
Net Income-9.61B
EPS-371.66
Shares Out47.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume923,395
Average Volume1,152,991
Open3,470.00
Previous Close3,480.00
Day's Range3,200.00 - 3,470.00
52-Week Range1,127.00 - 4,925.00
Beta0.47
RSI44.15
Earnings DateMar 17, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements